Merck hands over $20M in IBD drug target deal with Flagship's Quotient Read more 

Innovent sees path to China approval after eye disease drug matches Eylea in phase 3 Read more 

Fierce Biotech Fundraising Tracker '26: Immutrin's $87M series A; Crossbow targets $77M Read more 

About Ella Johnson

This author has not yet filled in any details.
So far Ella Johnson has created 5 blog entries.
Go to Top